Cargando…
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Non-invasive predictive assays which can confirm the presence or absence of hypoxic cells in human tumours show promise for understanding the natural history of tumour oxygenation, and improving the selection of patient subsets for novel radiotherapeutic strategies. Sensitiser adducts have been prop...
Autores principales: | Parliament, M. B., Chapman, J. D., Urtasun, R. C., McEwan, A. J., Golberg, L., Mercer, J. R., Mannan, R. H., Wiebe, L. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977349/ https://www.ncbi.nlm.nih.gov/pubmed/1310253 |
Ejemplares similares
-
Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
por: Parliament, M. B., et al.
Publicado: (1992) -
Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [(123)I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress †
por: Stypinski, Daria, et al.
Publicado: (2018) -
Pilot study of PET imaging of (124)I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer
por: O’Donoghue, Joseph A, et al.
Publicado: (2013) -
A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979) -
Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983)